The urgent need for randomized controlled trials in pregnant women with antiphospholipid antibodies—protecting women through research

IntroductionObstetric antiphospholipid syndrome (OAPS) is an autoimmune disorder associated with pregnancy morbidity, including recurrent pregnancy loss, preeclampsia and fetal growth restriction. Despite standard of care (SoC) with low-dose aspirin (LDA) and low-molecular-weight heparin (LMWH), 20%...

Full description

Bibliographic Details

Main Authors:	Christine Graversgaard Adams, Jullie Rudnicki, Berit Fabricius Petersen, Søren Jacobsen, Karen Schreiber
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2026-02-01
Series:	Frontiers in Lupus
Subjects:	antiphospholipid antibodies obstetric APS randomized controlled trials refractory obstetrical APS evidence gap
Online Access:	https://www.frontiersin.org/articles/10.3389/flupu.2026.1747204/full
Tags:	Add Tag No Tags, Be the first to tag this record!